Cargando...
Harnessing the immune response to target tumors
Development of “immune-based targeted therapy” in oncology has limited experience with signal pathway modulation. However, as we have become better versed in understanding immune function related to anticancer response, “hints” of specific targets associated with sensitivity and resistance have been...
Gardado en:
| Publicado en: | F1000Res |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
F1000Research
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5461900/ https://ncbi.nlm.nih.gov/pubmed/28620466 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.10795.1 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|